Cannabis Industry Rallies After Biden's Pardons

President Biden announced an unprecedented move to pardon Americans who have been convicted of marijuana possession charges. Could this be the beginning of a comeback for the marijuana industry?

 · 10/19/2022
diamonds

It’s happening. No, really. It’s happening. What was once deemed an impossible concession by cannabis activists has become a reality as President Joe Biden announced a surprising move to pardon people convicted of marijuana possession charges. And that’s not all. In the same speech, the 46th President stated: “I am asking the Secretary of Health and Human Services and the Attorney General to initiate the administrative process to review expeditiously how marijuana is scheduled under federal law.” This is crucial to note, as it could set the path toward legalization. 

How Did the Industry React?

Unsurprisingly, this was welcoming news for the cannabis sector. Individual stocks like Tilray appreciated by as much as 30%, while Canopy rose more than 20%. Industry insiders are speculating Biden’s decision might eventually pave the path toward a more holistic approach to how the government classifies marijuana, with hopes of eventual legalization. The CEO of StateHouse Holdings Inc, a California-based cannabis company stated:

“We are, first of all, delighted that the President is pardoning the many thousands of people whose lives have been horribly impacted by minor possession offenses. Secondly, we believe that re-scheduling, or outright de-scheduling, of cannabis would be a very positive catalyst for the legal industry.”

Some profess this move is long overdue. Karan Wadhera, managing partner at Casa Verde Capital who sits on the board of ten cannabis firms expressed: “This is massive. Both for the industry and obviously from a social equity perspective. People have been waiting for this ever since Biden took office.”

Marijuana Industry Outlook 

The future looks bright for this multi-billion dollar industry. Its projected growth rate in terms of CAGR (compound annual growth rate) is 28% -- not too shabby! Furthermore, the market as a whole is projected to increase to an astounding 97 billion between now and 2026. 

Aside from the plant’s use as a recreational drug, marijuana has also been used to treat various medical conditions and symptoms including pain relief, muscle spasms, inflammation and insomnia. In recent years, cannabis has also been associated with its ability to treat post-traumatic stress disorder and anxiety. If policymakers continue to soften their stance, the industry could stand to benefit tremendously in the years to come, both in terms of recreation and therapeutic use. 

It is important to consider the inherent risks this nascent industry brings, including the possibility of extreme volatility - and potentially losing your initial investment - given the highly speculative and politically sensitive nature of this investment space. However, for investors seeking exposure to the cannabis industry the following funds may be of interest:   

HMUS – (Horizons US Marijuana Index ETF)

  • AUM: $11.1 M 
  • Expense Ratio: 0.35%
  • 1-Month Performance: -6.53%
  • 3-Month Performance: -10.44%

HMJU – (Horizons BetaPro Marijuana Companies 2x Daily Bull ETF) 

  • AUM: $2.4M 
  • Total Expense Ratio: 2.05%
  • 1-Month Performance: -26.87%
  • 3-Month Performance: -33.44%

HMMJ – (Horizons Marijuana Life Sciences Index ETF) 

  • AUM: $131.9 M 
  • Expense Ratio: 0.85%
  • 1-Month Performance: -3.81%
  • 3-Month Performance: -8.19%

Final takeaway 

At this juncture, putting your money on marijuana is a high-risk, high-reward investment. At present, marijuana is still deemed as a Schedule 1 substance and there is no guarantee that it will change. Although President Biden’s pardons are welcome news, the decision as to whether or not there is a path forward for decriminalization, and eventually full legalization, is anyone’s guess right now. 

Data as of October 18, 2022.

Disclaimer: This article is limited to the dissemination of general information pertaining to investment strategies and financial planning and does not constitute an offer to issue or sell, or a solicitation of an offer to subscribe, buy, or acquire an interest in, any securities, financial instruments or other services, nor does it constitute a financial promotion, investment advice or an inducement or incitement to participate in any product, offering or investment.

Issuer insights

Partner content

Issuer Insights | Franklin Core Equity ETFs: How Systematic Strategies Answer Investor Needs

Franklin Templeton’s Michael Greenberg explains how a risk-controlled, multi-factor equity core can free up fee and risk budget for higher-conviction positions elsewhere in a portfolio.

Sponsored by Franklin Templeton

Issuer Insights | Beyond the Benchmark: A Smart Way to Build Your Core Portfolio

Issuer Insights | Beyond the Benchmark: A Smart Way to Build Your Core Portfolio

Fee pressure and concentrated markets are pushing advisors to rethink the core of client portfolios. In our latest piece, Franklin Templeton’s Michael Greenberg makes the case for a factor-based core that blends benchmark exposure with systematic alpha, and explains how to decide whether to replace, complement or consolidate existing positions.

Sponsored by Franklin Templeton

Issuer Insights | Moats Mater in 2026: Meet FDIV

Issuer Insights | Moats Mater in 2026: Meet FDIV

A closer look at FDIV’s three-pillar approach—quality, growth, and income—and how it can serve as a core or satellite allocation in U.S. equity portfolios.

Sponsored by Franklin Templeton

issuer Insights | 2026: Global Diversification Is In

Issuer Insights | 2026: Global Diversification Is In

Looking beyond North America may be the smart move for 2026. In our recent Issuer Insights episode from ETF Market Canada, Ahmed Farooq of Franklin Templeton Investments highlighted how international markets, driven by European infrastructure and defense spending and Asia’s AI boom, are outperforming the U.S.

Sponsored by Franklin Templeton

Alex Lee FLVI

Issuer Insights | FLVI and How Investors Can Tackle Volatility

In our latest episode of Issuer Insights, Alex Lee, Canadian Head of ETF Product Strategy at Franklin Templeton Investments, discusses how #investors are navigating uncertainty - from market volatility to global diversification trends.

Sponsored by Franklin Templeton

V1 - FMID Issuer Insights Thumbnail

Issuer Insights | Navigating Bond Markets with Active Fixed Income ETFs

Sponsored by Franklin Templeton

Isseur Insights - Volatility

Issuer Insights | Staying Resilient Through Market Volatility

Sponsored by Franklin Templeton

Issuer Insights | Franklin U.S. Mid Cap Multifactor Index ETF (FMID)

Issuer Insights | Franklin U.S. Mid Cap Multifactor Index ETF (FMID)

Sponsored by Franklin Templeton

Issuer Insights | Finding the Sweet Spot in Bond Investing

Issuer Insights: Finding the Sweet Spot in Bond Investing

Sponsored by Franklin Templeton

Issuer Insights | Franklin Canadian Ultra Short Term Bond Fund (FHIS)

Issuer Insights: Franklin Canadian Ultra Short Term Bond Fund (FHIS)

Sponsored by Franklin Templeton

Issuer Insights Thumbnail

Issuer Insights: Franklin Multi-Asset ETF Portfolio

Sponsored by Franklin Templeton

ETF Education Centre

CboeTrackinsight
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.

All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
diamonds
Get ETF updates by email

Never miss the latest Canadian ETF Investing news and updates